Manufacturer record

Morepen Laboratories Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

10 batches manufactured by Morepen Laboratories Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2020 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

10 records linked to Morepen Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
10Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2020 to Aug 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

10
NSQ batches since 2020
8
Products affected
Dissolution
Most common failure
Aug 2025
Latest alert

Flagged batches per year

2020 · 12021 · 32022 · 32024 · 12025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Rabeprazole Gastro-resistant Tablets IP 20 mg F4L0950Mfg 2024-12 · Exp 2026-11 DissolutionDissolution CDTL, MumbaiCDSCO lab Aug 2025
AMLOPEN 2.5 (Amlodipine Besylate Tablets I.P. 2.5 mg) E4B0148Mfg 2024-02 · Exp 2026-01 The sample does not conform to standard quality in respect of the test for ?Dissolution? performedDissolution State Drugs Testing Laboratory, Agartala, TripuraState lab Jul 2025
Domperidone Tablets IP 10 mg (Domipen Tablets) E2K0571Mfg 2022-11 · Exp 2024-10 Identification AIdentification RDTL ChandigarhState lab Mar 2024
CalciQuick-500 (Calcium and Vitamin D3 Tablets I.P.) T-1B0038Mfg 2021-02 · Exp 2023-01 Identification & Assay of Vitamin D3Assay CDL KolkataCDSCO lab Jul 2022
MONTELUKAST TABLETS IP 10 MG C-1D0342Mfg 2021-04 · Exp 2023-03 DissolutionDissolution RDTL ChandigarhCDSCO lab Jun 2022
CalciQuick-500 (Calcium and Vitamin D3 Tablets I.P.) T-1H0250Mfg 2021-08 · Exp 2023-07 Assay of Vitamin D3Assay CDL KolkataCDSCO lab Apr 2022
BISACODYL GASTRO - RESISTANT TABLETS IP 5 MG C-0L0933Mfg 2020-12 · Exp 2022-11 DissolutionDissolution RDTL ChandigarhCDSCO lab Sep 2021
Orvastin-40 (Atorvastatin Tablets I.P. 40 mg) P-0C0154Mfg 2020-03 · Exp 2022-08 DissolutionDissolution CDTL MumbaiCDSCO lab Jul 2021
ORVASTIN-20 (Atorvastatin Tablets IP 20 mg) P-0H0440Mfg 2020-08 · Exp 2023-01 DissolutionDissolution CDTL MumbaiCDSCO lab Apr 2021
ReGermina (Prebiotic & Probiotics Capsules) P90087Mfg 2019-02 · Exp 2020-06 Content of Streptococcu s faecalis and Clostridium butyricumOther CDL KolkataCDSCO lab May 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.